Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate panel backs AB 669 to guarantee minimally 28 days of uninterrupted residential addiction treatment for insured patients
Summary
AB 669 would require insurers to ensure at least 28 days of uninterrupted addiction treatment and limit early discharge driven by utilization review panels; supporters cited overdose deaths and clinical need, while insurers said they were "oppose unless amended." Committee moved the bill forward as amended.
AB 669, a bill to require insurers to cover at least 28 continuous days of residential addiction treatment without premature discharge driven by insurer utilization panels, was advanced by the Senate Health Committee after emotional testimony from family members and addiction clinicians.
Assemblymember Haney, the bill’s author, said insurers sometimes use corporate review panels that “have no contact at all with the patient, no contact at all with their doctors, and use that process to deny the coverage that folks in our state critically need.” He cited other states (New York, New Jersey, Massachusetts, Delaware) that have enacted similar…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
